Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Akero Therapeutics Inc shares valued at $351,890 were sold by Yale Catriona on Nov 06 ’24. At $35.19 per share, Yale Catriona sold 10,000 shares. The insider’s holdings dropped to 74,158 shares worth approximately $2.3 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, CATRIONA YALE purchased 10,000 shares, netting a total of over 327,400 in proceeds.
Before that, Young Jonathan had sold 50,716 shares from its account. In a trade valued at $1,601,252, the Chief Operating Officer traded Akero Therapeutics Inc shares for $31.57 each. Upon closing the transaction, the insider’s holdings decreased to 50,716 shares, worth approximately $6.7 million.
Analysts at Cantor Fitzgerald started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid September. As of August 28, 2023, UBS has initiated its “Buy” rating for AKRO. Earlier on January 27, 2023, Morgan Stanley upgraded its rating. Their new recommendation was “an Overweight” for AKRO stock which previously was a “an Equal-weight”.
Analyzing AKRO Stock Performance
During the last five days, there has been a drop of approximately -12.22%. Over the course of the year, Akero Therapeutics Inc shares have jumped approximately 32.63%. Shares of the company reached a 52-week high of $37.00 on 03/04/24 and a 52-week low of $15.32 on 02/06/24. A 50-day SMA is recorded $29.36, while a 200-day SMA reached $25.04. Nevertheless, trading volume fell to 0.54 million shares from 0.68 million shares the previous day.
Support And Resistance Levels for Akero Therapeutics Inc (AKRO)
According to the 24-hour chart, there is a support level at 30.35, which, if violated, would cause prices to drop to 29.73. In the upper region, resistance lies at 32.19. The next price resistance is at 33.40. RSI (Relative Strength Index) is 49.06 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.04, which suggests the price will decrease in the coming days. Percent R is at 70.93%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
